Revenue
attach_money14,343M USD
YoY +1.0%
REGNRegeneron Pharmaceuticals, Inc.$ --
Regeneron Pharmaceuticals, Inc.
REGN
$ -
-
You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.
analyticsIncome Statement Summary
FY2025 Full YearUpdated: 12/31/2025
Operating Income
bar_chart3,578M USD
YoY -10.3%
Net Income
verified4,505M USD
YoY +2.1%
EPS
pie_chart43.07USD
YoY +5.3%
Quarterly Performance
Quarterly revenue and net income trend
RevenueOperating IncomeNet Income
No quarterly data available
Full-Year Progress
Net Income Progress17.1%Below Target
Revenue Progress3.6B
Revenue Forecast15.7B
Net Income Progress727.2M
Net Income Forecast4.3B
Income Statement Details
Item
Revenue
Cost of revenue
Gross profit
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
Interest expense
Income before tax
Income tax expense
Net income
Unlock Long-Term Income Statement Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.